ZA200901853B - Pegylated PTH as PTH receptor modulators and uses thereof - Google Patents

Pegylated PTH as PTH receptor modulators and uses thereof

Info

Publication number
ZA200901853B
ZA200901853B ZA200901853A ZA200901853A ZA200901853B ZA 200901853 B ZA200901853 B ZA 200901853B ZA 200901853 A ZA200901853 A ZA 200901853A ZA 200901853 A ZA200901853 A ZA 200901853A ZA 200901853 B ZA200901853 B ZA 200901853B
Authority
ZA
South Africa
Prior art keywords
pth
pegylated
receptor modulators
pth receptor
modulators
Prior art date
Application number
ZA200901853A
Other languages
English (en)
Inventor
Patricia Lea Brown-Augsburger
Wayne David Kohn
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA200901853B publication Critical patent/ZA200901853B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA200901853A 2006-10-13 2009-03-16 Pegylated PTH as PTH receptor modulators and uses thereof ZA200901853B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82938306P 2006-10-13 2006-10-13

Publications (1)

Publication Number Publication Date
ZA200901853B true ZA200901853B (en) 2010-05-26

Family

ID=38974655

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901853A ZA200901853B (en) 2006-10-13 2009-03-16 Pegylated PTH as PTH receptor modulators and uses thereof

Country Status (12)

Country Link
AR (1) AR063251A1 (zh)
CL (1) CL2007002876A1 (zh)
CO (1) CO6190624A2 (zh)
CR (1) CR10681A (zh)
CY (1) CY1110701T1 (zh)
DE (1) DE602007006839D1 (zh)
ES (1) ES2343917T3 (zh)
MA (1) MA30873B1 (zh)
PE (1) PE20080981A1 (zh)
PT (1) PT2084183E (zh)
TW (1) TW200817439A (zh)
ZA (1) ZA200901853B (zh)

Also Published As

Publication number Publication date
CR10681A (es) 2009-07-13
AR063251A1 (es) 2009-01-14
ES2343917T3 (es) 2010-08-12
CL2007002876A1 (es) 2008-06-06
CO6190624A2 (es) 2010-08-19
MA30873B1 (fr) 2009-11-02
CY1110701T1 (el) 2015-06-10
PT2084183E (pt) 2010-07-16
TW200817439A (en) 2008-04-16
PE20080981A1 (es) 2008-07-19
DE602007006839D1 (de) 2010-07-08

Similar Documents

Publication Publication Date Title
IL198990A0 (en) Cb1 receptor modulators
GB0400440D0 (en) Receptor modulators
IL211802A0 (en) Nmda receptor modulators and uses thereof
IL184657A0 (en) Adam-9 modulators
EP1885855A4 (en) CYTOKIN RECEPTOR MODULATORS AND USES THEREOF
EP2117080A4 (en) HARNESS CONNECTING ELEMENT
EP2024334A4 (en) SUBSTITUTED ESTERS AS CANNABINOID-1 RECEPTOR MODULATORS
IL199085A0 (en) Interleukin-21 variants with altered binding to the il-21 receptor
IL189846A0 (en) Theramutein modulators
IL191766A0 (en) Gaba-b receptor modulators
GB0701992D0 (en) Grehlin Receptor Modulators
EP1915162A4 (en) MODULATORS
PL2094684T3 (pl) 1,5-difenylo-3-benzyloamino-1,5-dihydropirolidyn-2-ony jako modulatory receptora CB1
EP2155889A4 (en) TOLL RECEPTOR 3 MODULATORS AND USES THEREOF
EP2025229A4 (en) MICRO CAPSULE
IL188314A0 (en) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
GB0622569D0 (en) Cannabinoid receptor modulators
EP1945213A4 (en) MODULATORS OF THE R3-PIPERIDINE-4-YL-INDOLE ORL-1 RECEPTOR
EP2067480A4 (en) MUSCLIN RECEPTOR AND USE THEREOF
ZA200806237B (en) Cannibinoid receptor modulators
ZA200901853B (en) Pegylated PTH as PTH receptor modulators and uses thereof
GB0901012D0 (en) Harness
ZA200904663B (en) CB1 receptor modulators
GB0807710D0 (en) Receptor and modulators thereof
GB2444325B (en) Mixing